LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages
LB Pharmaceuticals Inc (NASDAQ:LBRX) has received a "Moderate Buy" consensus rating from ten brokerages, with an average 12-month price target of $45.13, closely aligning with its current trading price of $45.03. Recent analyst coverage, including BMO Capital Markets and HC Wainwright, has been largely …